Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine after esophagectomy to improve postoperative sublingual microcirculation
NL-OMON26013Recruiting
- Sponsor
- Erasmus MC
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dobutamine in esophageal disease (2 arms), sponsored by Erasmus MC. Primary endpoints: Functional capillary density, Perfused vessel density and 1 more. Started May 2010; status: recruiting.
02
Drugs
dobutamine
03
Conditions
esophageal disease
Beyond the preview
Go deeper on NL-OMON26013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26013.